Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Straumann Holding    STMN   CH0012280076

STRAUMANN HOLDING (STMN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
01/14/2019 01/15/2019 01/16/2019 01/17/2019 01/18/2019 Date
667(c) 665.5(c) 675.5(c) 707(c) 713.5(c) Last
47 277 35 831 47 726 94 261 43 872 Volume
+0.30% -0.22% +1.50% +4.66% +0.92% Change
More quotes
Financials (CHF)
Sales 2018 1 348 M
EBIT 2018 346 M
Net income 2018 283 M
Finance 2018 173 M
Yield 2018 0,73%
Sales 2019 1 548 M
EBIT 2019 411 M
Net income 2019 350 M
Finance 2019 329 M
Yield 2019 0,87%
P/E ratio 2018 40,21
P/E ratio 2019 32,44
EV / Sales2018 8,28x
EV / Sales2019 7,10x
Capitalization 11 330 M
More Financials
Company
Straumann Holding specializes in the design, manufacture and marketing of dental products and materials. Net sales break down by activity as follows: - sales of dental products (60.8%): implants, surgical instruments, diagnostic tools (distance indicators for implants, drilling guides, etc.),... 
More about the company
Surperformance© ratings of Straumann Holding
Trading Rating : Investor Rating :
More Ratings
Latest news on STRAUMANN HOLDING
01/17AD-HOC : Straumann Group set to enter clear aligner market in China
TE
01/15Straumann Group announces leadership succession plan
TE
2018Straumann Group and Nobel Biocare settle patent dispute
TE
2018Straumann partners with Z-Systems to offer the broadest range of ceramic impl..
TE
2018STRAUMANN : 2018 Straumann-botiss YoungPro Award goes to Piero Papi
PU
2018STRAUMANN : sustains strong performance, as organic revenue rises 18% both in Q3..
PU
2018STRAUMANN : The rationale for Straumann Switzerland's initiative to offer custom..
PU
2018INVITATION : Straumann Group 2018 Third-quarter sales report webcast
TE
2018Straumann launches another string of new products at the EAO
TE
2018Straumann Group strengthens foothold in low cost implant segment
TE
More news
Analyst Recommendations on STRAUMANN HOLDING
More recommendations
Sector news : Medical Prosthetics
01/17BECTON DICKINSON AND : Says First-Quarter Profit Will Top Views
DJ
01/16PG&E to get pulled out of S&P 500, shares near 2001 lows
RE
01/16ABBOTT LABORATORIES : Exercises Option to Buy Cephea Valve Technologies
DJ
01/14ABBOTT LABORATORIES : Labs Gets FDA Approval for Amplatzer Piccolo Occluder
DJ
01/10Hearing aid makers Widex and Sivantos reopen EU merger application
RE
More sector news : Medical Prosthetics
Chart STRAUMANN HOLDING
Duration : Period :
Straumann Holding Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRAUMANN HOLDING
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 788  CHF
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Marco Gadola Chief Executive Officer
Gilbert Achermann Chairman
Gerhard Bauer Head-Research, Development & Operations
Peter Hackel Chief Financial Officer
Thomas Straumann Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
STRAUMANN HOLDING15.45%11 374
ABBOTT LABORATORIES-1.26%125 437
MEDTRONIC PLC-3.69%117 248
BECTON, DICKINSON AND COMPANY7.44%63 620
STRYKER CORPORATION6.89%62 695
ESSILORLUXOTTICA1.45%54 324